ProShare Advisors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,537
| Closed | -$205K | – | 1879 |
|
|
2022
Q3 | $205K | Buy |
+5,537
| New | +$205K | ﹤0.01% | 1398 |
|
|
2022
Q2 | – | Sell |
-7,526
| Closed | -$203K | – | 2063 |
|
|
2022
Q1 | $203K | Buy |
+7,526
| New | +$203K | ﹤0.01% | 1879 |
|
|
2021
Q3 | – | Sell |
-6,910
| Closed | -$221K | – | 2215 |
|
|
2021
Q2 | $221K | Buy |
6,910
+745
| +12% | +$23.8K | ﹤0.01% | 2094 |
|
|
2021
Q1 | $217K | Buy |
+6,165
| New | +$217K | ﹤0.01% | 1992 |
|